Triamcinolone-augmented glucose tolerance in non-diabetic patients with chronic pancreatitis.


Seven non-diabetic patients with chronic pancreatitis were shown to have a diminished acute insulin secretory response after intensive beta cell and intravenous tolbutamide stimulation. In an attempt to unmask their 'latent' diabetic state, triamcinolone-augmented glucose tolerance tests were performed some days after documenting normal standard 50 g oral… (More)


3 Figures and Tables

Slides referencing similar topics